Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 2004 valuation

2004 valuation

posted on Mar 03, 2008 01:14AM

PTSC previously reported that Relational Advisors told the company that it represents TPL, Daniel Leckrone and Charles Moore in their effort to obtain PTSC ownership of patents (US5809336, 6598148, 5440749, 5604915, 5530890, 5784584 and 5659703). The $7.5 million offer included a royalty-sharing scheme deemed inadequate for the intellectual property held by PTSC, which has value estimations in excess of $1 billion. To clarify, Relational Advisors simply communicated the offer to PTSC in its capacity as financial advisor to TPL.

 

That was in November 2004, before the joint venture and subsequent licensing. I therefore humbly suggest that this talk of any takeover for $1 or $2 per share is not only laughable, but has no basis in fact.

 

 

 

Be well

Share
New Message
Please login to post a reply